A Study to Evaluate the Efficacy and Safety of MW02 in the Treatment of nAMD
Status:
Recruiting
Trial end date:
2024-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of MW02 versus Lucentis in
the treatment of neovascular age-related macular degeneration.The study was divided into two
stages. The first stage was to explore the dose and the second stage was to explore the
frequency of administration.